Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?

Overview of attention for article published in Frontiers in Medicine, December 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,865 followers.

RT @radonclibrary: Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand? https://t.co/JOV3e3k52M #radonc

10 Jan 2023

Reply Repost Favourite

RT @FrontMedicine: New Research: Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?: Targeted alpha therapy…

30 Dec 2022

Reply Repost Favourite

New Research: Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?: Targeted alpha therapy is an oncological treatment, where cytotoxic doses of alpha radiation are locally delivered to… https://t.co/fUf4nLtVTi #medicalcare #c

30 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.